Sandy Srinivas, MBBS, Stanford Cancer Center
Advertisement
Articles by Sandy Srinivas, MBBS, Stanford Cancer Center
Advertisement
Latest Updated Articles
Optimizing Use of PSMA PET Imaging and PSADT in Prostate CancerPublished: March 30th 2022 | Updated:
Adjuvant Therapy Approaches for Operable RCCPublished: August 10th 2021 | Updated:
Frontline Metastatic RCC: Nivolumab Plus CabozantinibPublished: July 13th 2021 | Updated:
Selecting Optimal Therapy for mHSPC: Design of the ARASENS TrialPublished: April 27th 2022 | Updated:
Overview of Improvements in Prostate Cancer ManagementPublished: March 30th 2022 | Updated:
Overview of Treatment for Metastatic HSPCPublished: April 20th 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5